To counter this limitation, a group of GLP-1 receptor agonists (GLP-1RAs), which are resistant to DPP4-mediated degradation [32], have been developed and shown to be effective in treating T2DM and obesity [33]
No, patients should not commence GLP-1 receptor agonists solely for potential cognitive effects without medical consultation
& Piva, J
Moreover, the slow and steady weight loss experienced by semaglutide users contributes to the sustainability of the weight loss, helping individuals maintain their new weight with less difficulty compared to conventional methods, which often result in rapid weight regain
The choice between them involves factors beyond just weight loss efficacy, including side effect profiles , cost, availability, and individual metabolic considerations
Phoenix NP Makes It Simple At Phoenix NP, we eliminate the guesswork